Tiotropium (Spiriva)

Indications


Pharmacology

  • Long-Acting Anticholinergic-Muscarinic Receptor Antagonist (LAMA) (see Muscarinic Antagonists, [[Muscarinic Antagonists]])
    • Bronchodilation

Metabolism

  • xxx

Administration

  • INH: 1 cap qday

Dose Adjustment

  • Hepatic
  • Renal

Adverse Effects

Pulmonary Adverse Effects

  • xxx
  • xxx

Other Adverse Effects

  • xxx
  • xxx

References

  • xxx